US Stock MarketDetailed Quotes
MXCT MaxCyte
- 3.950
- +0.070+1.80%
Close Apr 19 16:00 ET
- 3.950
- 0.0000.00%
Post 16:03 ET
411.31MMarket Cap-10675P/E (TTM)
3.970High3.810Low534.11KVolume3.850Open3.880Pre Close2.10MTurnover0.58%Turnover RatioLossP/E (Static)104.13MShares5.54552wk High1.77P/B361.30MFloat Cap2.45052wk Low--Dividend TTM91.47MShs Float17.440Historical High--Div YieldTTM4.12%Amplitude2.450Historical Low3.922Avg Price1Lot Size
MaxCyte Stock Forum
Sign in to post a comment
ColumnsToday's pre-market stock movers: DAL, JPM, NSTG, ATRS and more
Gainers:
•$Antares Pharma(ATRS.US$ +48.7% (to be acquired by Halozyme (HALO) for $5.60 per share)
•$Sierra Oncology(SRRA.US$ +37.9% (acquired by GSK for $55 per share)
•$Amryt Pharma(AMYT.US$ +11.7% (announces positive long-term safety and efficacy data for Mycapssa (oral octreotide) from the 2nd Year of OPTIMAL open label extension study in acromegaly patients)
•$BriaCell Therapeutics(BCTX.US$ +6% (presents development details of...
•$Antares Pharma(ATRS.US$ +48.7% (to be acquired by Halozyme (HALO) for $5.60 per share)
•$Sierra Oncology(SRRA.US$ +37.9% (acquired by GSK for $55 per share)
•$Amryt Pharma(AMYT.US$ +11.7% (announces positive long-term safety and efficacy data for Mycapssa (oral octreotide) from the 2nd Year of OPTIMAL open label extension study in acromegaly patients)
•$BriaCell Therapeutics(BCTX.US$ +6% (presents development details of...
12
4
$MaxCyte(MXCT.US$ come riseee
1
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Vhetration69 : d
SLLS : Nice
Be a voice no echo : up
Trytosaveabit Be a voice no echo: Great phase 3 results!